Nuvectis Pharma, Inc. (NVCT)

9.75 -0.44 (-4.32%) USD  |  NASDAQ  |  May 29, 16:00
9.80 +0.05 (+0.51%) After-Hours: 20:00
More

Nuvectis Pharma EPS Diluted (Quarterly) : -0.2584 for March 31, 2026

EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for NVCT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 0.0211
Alnylam Pharmaceuticals, Inc. 1.508
Anika Therapeutics, Inc. -0.3737
Savara, Inc. -0.1472
Vericel Corp. -0.1241

EPS Diluted (Quarterly) Related Metrics

Net Income (Quarterly) -6.05M
Total Expenses (Quarterly) 6.05M
Enterprise Value 233.49M
Earnings Yield -13.08%
Normalized Earnings Yield -13.08